Results 101 to 110 of about 378 (110)

TAFRO subtype of idiopathic multicentric Castleman disease in a 22-year-old man. [PDF]

CMAJ
Rowe S, Collins BW, Pirzada A, Manning N, Chen LYC.   +4 more
europepmc   +1 more source

Castleman Disease-Still More Questions than Answers: A Case Report and Review of the Literature. [PDF]

J Clin Med
Sikora M, Dąbrowska-Leonik N, Buda P, Wolska-Kuśnierz B, Jahnz-Różyk K, Pac M, Więsik-Szewczyk E.   +6 more
europepmc   +1 more source

Idiopathic multicentric Castleman disease in children: a single-center retrospective analysis. [PDF]

BMC Pediatr
Du J, Yao J, Ma H, Li L, Wei A, Zhang L, Wang D, Li Z, Zhang R, Wang T.   +9 more
europepmc   +1 more source

[The guidelines for the diagnosis and treatment of Castleman disease in China (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Hematological Rare Disease Academic Group, Chinese Society of Hematology, Chinese Medical Association, China Castleman Disease Network (CCDN).   +3 more
europepmc   +1 more source

Iptacopan in C5 blockade refractory atypical hemolytic uremic syndrome with associated Castleman's disease: case report. [PDF]

BMC Nephrol
Nguyen MD, Ciurea S, Desai S, Kalebasty AR, Tran MH, Gee C, Tadros M, Nguyen VQ, Patel S, Selamet U, Hanna R.   +10 more
europepmc   +1 more source

A Phase Ib Investigator-Initiated Trial of Filgotinib in Patients With Idiopathic Multicentric Castleman Disease. [PDF]

Cureus
Fukui S, Sumiyoshi R, Koga T, Hosogaya N, Narita S, Morimoto S, Yano H, Katsube A, Yano S, Masaki Y, Tsunoda S, Sato S, Migita K, Matsuyama K, Kato N, Kawamoto A, Kawakami A.   +16 more
europepmc   +1 more source

Idiopathic Multicentric Castleman's Disease as a Mimicker of IgG4-related Disease. [PDF]

Intern Med
Yoshimi R, Nakajima H.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Idiopathic Multicentric Castleman’s Disease (iMCD)-TAFRO Syndrome with Atypical Renal Biopsy Findings

Journal of the American Society of Nephrology, 2023
Ciara L. Chen, Karen Strenge, Trevor W. Tobin   +2 more
openaire   +1 more source

The involvement of PI3K-Akt signaling in the clinical and pathologic findings of iMCD-TAFRO and NOS subtypes.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Idiopathic multicentric Castleman disease is a rare lymphoproliferative disorder that is clinically classified into idiopathic plasmacytic lymphadenopathy (IPL); thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO); and not otherwise specified (NOS).
Tomoka, Haratake, Midori Filiz, Nishimura, Asami, Nishikori, Michael V, Gonzalez, Daisuke, Ennishi, You Cheng, Lai, Sayaka, Ochi, Manaka, Tsunoda, David C, Fajgenbaum, Frits van, Rhee, Shuji, Momose, Yasuharu, Sato   +11 more
openaire   +1 more source